Please login to the form below

Not currently logged in
Email:
Password:

Peter Goold and Colin White join Penn Pharma

Appointed to senior roles in supply chain team

Colin White - Penn PharmaPenn Pharma has appointed Peter Goold and Colin White (pictured) to senior positions in its supply chain team.

Peter Goold will take over the newly created role of director of supply chain and project management at the UK-based pharma services company, while Colin White has been appointed as head of manufacturing, running the production operation at Penn's UK facility.

Penn's chief executive, Dr Richard Yarwood said: “Peter and Colin join Penn at an integral point in the company's growth. Their strong technical backgrounds in their respective areas and vast customer service experience in outsourcing will be a great asset to the Penn brand.”

This growth includes the construction of new facilities due to open in 2013 that will boost the company's manufacturing efforts.

According to Penn, Goold and White have a combined 30 years of experience in the pharmaceutical and outsourcing industry, which has included running global supply chain operations covering commercial packing, solid oral dose manufacturing, and sterile products production.

Goold said: “It is fantastic to be joining Penn at such a momentous stage in the company's growth. The growth plans in place are a great motivation to ensure additional business is secured for our new contained manufacturing operation.”

22nd June 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Chandler Chicco Companies US

Chandler Chicco Companies (CCC) is a global health communications group that delivers unmatched perspective and creative know-how. Today, healthcare is...

Latest intelligence

More of the same: The importance of strategic communications planning for biosimilar entry
GCI Health's Hannah Morris considers the importance of strategic communications planning for biosimilar entry, a market anticipated to deliver between €8-26bn in savings across the European Union by 2020....
Online Physician Communities
How can pharma realise the power of digital?
Firstly, by making it owned and driven by the most senior leadership team in the business...
Remapping the market: Does Pharma's global model need a shake up?
For patients, carers and professionals, wherever they are in the world, digital technology is inherent in their everyday lives. Digital is, so to speak, a global language. The success of...